Cancer Therapy : Preclinical Dual Inhibition of Canonical and Noncanonical NFk B Pathways Demonstrates Signi fi cant Antitumor Activities in Multiple Myeloma
暂无分享,去创建一个
P. Richardson | Yiguo Hu | T. Hideshima | Y. Tai | R. Carrasco | S. Kong | D. Cirstea | N. Mimura | K. Bobb | Ruben D Carrasco | J. Meshulam | H. Ohguchi | J. Minami | Jie Zhang | C. Fabre | K. Anderson